VIMOVO cpr pell 500mg/20mg bte 60 pce

7680613300082 CH-61330 M01AE52 07.10.2.

Active substances:

Reimbursement limitations:

BLUTPRODUKTE

Calcul des prix des préparations sanguines sur la base du prix « ex factory », …

VIMOVO cpr pell 500mg/20mg bte 60 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6133001
CPT
-
Packaging group
60
Unit
Tablette(n)
Composition
naproxenum 500 mg, esomeprazolum 20 mg ut esomeprazolum magnesicum trihydricum 22.3 mg, carmellosum natricum conexum corresp. natrium 2.11 mg, povidonum K 90, silica colloidalis anhydrica, magnesii stearas, hypromellosum, macrogolum 8000, triethylis citras, polysorbatum 80, glyceroli monostearas 40-55, propylis parahydroxybenzoas ca. 10 µg, E 218 ca. 20 µg, triethylis citras, polysorbatum 80, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, polydextrosum, hypromellosum, macrogolum 8000, E 171, hypromellosum, macrogolum 8000, polysorbatum 80, Überzug: hypromellosum, macrogolum 8000, E 171, E 172 (flavum), hypromellosum, macrogolum 8000, cera carnauba, Drucktinte: E 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto.

Articles (1)

Vimovo, Filmtabletten
Filmtabletten
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
21/07/2026
Professional SmPC
Français
21/07/2026
Professional SmPC
Italien
21/07/2026
Patient information leaflet
Allemand
17/07/2026
Patient information leaflet
Français
17/07/2026
Patient information leaflet
Italien
17/07/2026

Detailed composition

Substance Quantity Type Category
naproxenum
500.0 MG Substance Wirkstoff (Principe actif)
esomeprazolum
20.0 MG Substance Wirkstoff (Principe actif)
esomeprazolum magnesicum trihydricum
22.3 MG Substance WIZUS
carmellosum natricum conexum
- Substance HNIDK
natrium
2.11 MG Substance HBESI
povidonum K 90
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogolum 8000
- Substance HNIDK
triethylis citras
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
glyceroli monostearas 40-55
- Substance HNIDK
propylis parahydroxybenzoas
- Substance HBESI
E 218
- Substance HBESI
triethylis citras
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
acidi methacrylici et ethylis acrylatis polymerisatum 1:1
- Substance HNIDK
polydextrosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogolum 8000
- Substance HNIDK
E 171
- Substance FNIDK
hypromellosum
- Substance HNIDK
macrogolum 8000
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
hypromellosum
- Substance HNIDK
macrogolum 8000
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
hypromellosum
- Substance HNIDK
macrogolum 8000
- Substance HNIDK
cera carnauba
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
hypromellosum
- Substance HNIDK

Reimbursement information

Public price
CHF 39.55
Specialties list
Yes
Generic
No
SL addition date: 01/09/2022

Authorization holder

Grünenthal Pharma AG

None Glarus Süd

Authorization information

Swissmedic authorization number
61330
Drug name
Vimovo, Filmtabletten
Galenic form
FILM
ATC Code
M01AE52
Authorization status
Z
Dispensation category
B
First authorization
06/05/2011
Authorization expiration date
31/12/9999
IT number
07.10.2.
Domain
Human medicine
Field of application
Antirheumatikum kombiniert mit Protonenpumpenblocker

Packaging details

Description (FR)
VIMOVO cpr pell 500mg/20mg bte 60 pce
Description (DE)
VIMOVO Filmtabl 500mg/20mg Ds 60 Stk
Market launch
06/05/2011
Narcotic (BTM)
No

Available generics

Naproxen Esomeprazol Sandoz, Filmtabletten
CHF 25.75
View
Naproxen Esomeprazol Sandoz, Filmtabletten
CHF 35.10
View

Other packaging sizes

VIMOVO cpr pell 500mg/20mg 60 pce
60 TABL
View
VIMOVO cpr pell 500mg/20mg 30 pce
30 TABL
View
VIMOVO cpr pell 500mg/20mg bte 30 pce
30 TABL
View
Buy us a coffee Explore the data